(Q30832054)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Bladder sensory desensitization decreases urinary urgency (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

Carlos Silva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

João Silva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Helder Castro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Frederico Reis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Paulo Dinis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

António Avelino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

11 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms

31 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Current and future pharmacological treatment for overactive bladder

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Topography of the vanilloid receptor in the human bladder: more than just the nerve fibers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Vanilloid receptors: new insights enhance potential as a therapeutic target

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Using the circumstances of symptom experience to assess the severity of urgency in the overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Validation of the urgency perception scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-9

The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1903357

Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis

25 November 2018

1 reference

12 December 2020

Suppression of bladder hyperreflexia by intravesical resiniferatoxin

1 reference

12 December 2020

Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study

1 reference

12 December 2020

Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study

1 reference

12 December 2020

Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2490-7-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 December 2019

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2490-7-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561998%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

PubMed publication ID

17561998

1 reference